Oncology Nurses Must Watch for CAR T-Cell Therapy Side Effects

It is increasingly important that oncology nurses and other healthcare providers recognize cytokine release syndrome (CRS) and other side effects that can be triggered by anticancer treatment with engineered chimeric antigen receptor (CAR) T-cell therapies, and that they understand the importance of early detection, a speaker emphasized at the Oncology Nursing Society (ONS) 42nd Annual Congress, held May 4–7 in Denver.

“Careful monitoring is essential for early detection of CAR T-cell side effects,” said study coauthor Brenna Hansen, BSN, RN, OCN, a research nurse specialist at the Center for Cancer Research, National Cancer Institute, Bethesda, Maryland. “Early recognition of symptoms results in early intervention and safe management of the patient by the multidisciplinary team.”

Read Full Article Here >>